Profiling of genes which are differentially expressed in mouse liver in response to adenoviral vectors and delivered genes

Gene Therapy

Volumn 7, Issue 11, 2000, Pages 903-909

  Haberberger, T C ^a   Kupfer, K ^a   Murphy, J E ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Adenovirus; cDNA array; Connective tissue growth factor; Immune response; Transforming growth factor 1

Indexed keywords

COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; INTERFERON REGULATORY FACTOR 1; LAMININ RECEPTOR; MESSENGER RNA; SERINE PROTEINASE INHIBITOR; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIRUS VECTOR;

ADENOVIRUS; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GENE TARGETING; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BLOTTING, NORTHERN; BONE MORPHOGENETIC PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENETIC VECTORS; HEPATITIS, VIRAL, ANIMAL; INTERFERON REGULATORY FACTOR-1; LIVER; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; PEPTIDES; PHOSPHOPROTEINS; RECEPTORS, LAMININ; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE; ANIMALIA; RODENTIA;

EID: 0034086104     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301181     Document Type: Article

References (30)

1. Duggan DJ et al. Expression profiling using cDNA microarrays. Nat Genet 1999; 21: 10-14.
2. Shim C, Zhang W, Rhee CH, Lee JH. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 1998; 4: 3045-3050.
3. Sehgal A et al. Application of the differential hybridization of Atlas human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue. J Surg Oncol 1998; 67: 234-241.
4. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 1997; 214: 27-40.
5. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-161.
6. Terrell TG, Working PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol 1993; 34: 43-67.
7. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Diff 1996; 7: 469-480.
8. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997; 8: 171-179.
9. Ragot T, Opolon P, Perricaudet M. Adenoviral gene delivery. Meth Cell Biol 1997; 52: 229-260.
10. Yeh P, Perricaudet M. Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J 1997; 11: 615-623.
11. Czarniecki CW et al. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 1988; 140: 4217-4223.
12. Foster GR. Interferons in host defense. Semin Liver Dis 1997; 17: 287-295.
13. Wong P, Severns CW, Guyer NB, Wright TM. A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol Cell Biol 1994; 14: 914-922.
14. Bammler TK, Smith CA, Wolf CR. Isolation and characterization of two mouse Pi-class glutathione S-transferase genes. Biochem J 1994; 298: 385-390.
15. Ram PA, Park SH, Choi HK, Waxman DJ. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem 1996; 271: 5929-5940.
16. Akira S. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 1999; 17: 138-146.
17. Mori T et al. Role and interaction of connective tissue growth factor with transforming growtn factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 1999; 181: 153-159.
18. Brigstock DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999; 20: 189-206.
19. Fajardo LF et al. Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern. Lab Invest 1996; 74: 600-608.
20. Shimo T et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 1999; 126: 137-145.
21. Kessler E et al. Bone morphogenetic protein-1: The type-I procollagen C-proteinase. Science 1996; 271: 360-362.
22. Lee S et al. Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem 1997; 272: 19059-19066.
23. Li H et al. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Therapy 1998; 5: 1105-1113.
24. Shetty S et al. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am J Respir Cell Mol Biol 1996; 15: 78-87.
25. Blasi F. The urokinase receptor. A cell surface, regulated chemokine. APMIS 1999; 107: 96-101.
26. Pages G et al. Molecular characterization of three rat liver serineprotease inhibitors affected by inflammation and hypophysectomy. Protein and mRNA analysis and cDNA cloning. Eur J Biochem 1990; 190: 385-391.
27. Ikeda T et al. Anti-invasive activity of synthetic serine protease inhibitors and its combined effect with a matrix metalloproteinase inhibitor. Anticancer Res 1998; 18: 4259-4265.
28. Roeb E et al. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 1993; 18: 1437-1442.
29. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91: 8802-8806.
30. Fallaux FJ et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 215-222.